Mark E. Dmytruk - Chief Financial Officer at Ginkgo Bioworks Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
DNA on NYSE, DNABW on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Mark E. Dmytruk - trading volume in the past year for Ginkgo Bioworks Holdings, Inc.

Holdings reported by Mark E. Dmytruk for Ginkgo Bioworks Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 44.1K $341K $7.73 Mar 13, 2025 Direct
Class B Common Stock 5.91K $45.7K $7.73 Mar 13, 2025 Direct Class A Common Stock
Restricted Stock Units 4.25K $32.8K $7.73 Mar 6, 2025 Direct Class A Common Stock

Transactions reported by Mark E. Dmytruk for Ginkgo Bioworks Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.